L679-0238 Screening compound: N-(BUTAN-2-YL)-4-{[3-(4-FLUOROPHENYL)-3H-IMIDAZO[45-B]PYRIDIN-2-YL]METHYL}PIPERAZINE-1-CARBOXAMIDE

L679-0238 Screening compound: N-(BUTAN-2-YL)-4-{[3-(4-FLUOROPHENYL)-3H-IMIDAZO[45-B]PYRIDIN-2-YL]METHYL}PIPERAZINE-1-CARBOXAMIDE
L679-0238 Screening compound: N-(BUTAN-2-YL)-4-{[3-(4-FLUOROPHENYL)-3H-IMIDAZO[45-B]PYRIDIN-2-YL]METHYL}PIPERAZINE-1-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound L679-0238
N-(BUTAN-2-YL)-4-{[3-(4-FLUOROPHENYL)-3H-IMIDAZO[45-B]PYRIDIN-2-YL]METHYL}PIPERAZINE-1-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L679-0238

Molecular Formula

C22H27FN6O (C22 H27 FN6 O)

Compound Name

N-(BUTAN-2-YL)-4-{[3-(4-FLUOROPHENYL)-3H-IMIDAZO[45-B]PYRIDIN-2-YL]METHYL}PIPERAZINE-1-CARBOXAMIDE

IUPAC name

N-(butan-2-yl)-4-{[3-(4-fluorophenyl)-3H-imidazo[45-b]pyridin-2-yl]methyl}piperazine-1-carboxamide

SMILES

CCC(C)NC(N1CCN(Cc2nc3cccnc3n2-c(cc2)ccc2F)CC1)=O

InChI

InChI=1S/C22H27FN6O/c1-3-16(2)25-22(30)28-13-11-27(12-14-28)15-20-26-19-5-4-10-24-21(19)29(20)18-8-6-17(23)7-9-18/h4-10,16H,3,11-15H2,1-2H3,(H,25,30)/t16-/m0/s1

InChI Key

QPLKNWOAZPEUGT-INIZCTEOSA-N

MDL Number (MFCD)

MFCD27469048

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

410.49

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.576

Distribution Coefficient, logD

2.572

Water Solubility, LogSw

-2.73

Polar Surface Area

51.838

Acid Dissociation Constant (pKa)

17.25

Base Dissociation Constant (pKb)

5.34

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.91

L679-0238 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L679-0238 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L679-0238?
Check Price and Availability of L679-0238, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L679-0238 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L679-0238
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L679-0238
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L679-0238 available by request